22,403
Views
42
CrossRef citations to date
0
Altmetric
Review

The effect of e-cigarette aerosol emissions on respiratory health: a narrative review

, , , &
Pages 899-915 | Received 03 Jan 2019, Accepted 23 Jul 2019, Published online: 02 Aug 2019

References

  • Caponnetto P, Russo C, Bruno CM, et al. Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch Chest Dis. 2013;79:12–19.
  • Farsalinos KE, Romagna G, Tsiapras D, et al. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health. 2014;11:4356–4373.
  • Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17:127–133.
  • Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5:67–86.
  • Marco E, Grimalt JO. A rapid method for the chromatographic analysis of volatile organic compounds in exhaled breath of tobacco cigarette and electronic cigarette smokers. J Chromatogr A. 2015;1410:51–59.
  • Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23(suppl 2):ii36–ii40.
  • Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(Suppl 2):i11–i17.
  • Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133–139.
  • Margham J, McAdam K, Forster M, et al. Chemical composition of aerosol from an e-cigarette: a quantitative comparison with cigarette smoke. Chem Res Toxicol. 2016 Oct 17;29(10):1662–1678.
  • Rawlinson C, Martin S, Frosina J, et al. Chemical characterisation of aerosols emitted by electronic cigarettes using thermal desorption-gas chromatography-time of flight mass spectrometry. J Chromatogr A. 2017May12;1497:144–154.
  • Rodgman A, Perfetti TA. The chemical components of tobacco and tobacco smoke. 2nd ed. Boca Raton (FL): CRC Press;; 2013.
  • Royal College of Physicians. Nicotine without smoke. Tobacco harm reduction: report of the tobacco advisory group of the royal college of physicians. London: Royal College of Physicians; 2016.
  • McNeill A, Brose LS, Calder R, et al. E-cigarettes: an evidence update. A report commissioned by Public Health England. London: Public Health England; 2015.
  • Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20:218–225.
  • National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington, DC: The National Acad- emies Press; 2018. doi:10.17226/24952.
  • Sosnowski TR, Kramek-Romanowska K. Predicted deposition of e-cigarette aerosol in the human lungs. J Aerosol Med Pulm Drug Deliv. 2016;29(3):299–309.
  • Mikheev VB, Brinkman MC, Granville CA, et al. Real-time measurement of electronic cigarette aerosol size distribution and metals content analysis. Nicotine Tob Res. 2016;18(9):1895–1902.
  • Pichelstorfer L, Hofmann W, Winkler-Heil R, et al. Simulation of aerosol dynamics and deposition of combustible and electronic cigarette aerosols in the human respiratory tract. J Aerosol Sci. 2016;99:125–132.
  • Generally Recognized as Safe (GRAS). [Internet]. Washington, DC: U.S. Food & Drug Administration; 2017. Available from: https://www.fda.gov/food/ingredientspackaginglabeling/gras/
  • Cotta KI, Stephen CD, Mohammad NU. A review on the safety of inhalation of propylene glycol in E-cigarettes. Glob J Pharmaceu Sci. 2017;2(2):555584. Available at: https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555584.pdf.
  • Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med. 2001;58:649–655.
  • Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic nicotine delivery device (e-cigarette) on smoking cessation and reduction: a prospective pilot study. BMC Public Health. 2011;11:786.
  • Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8:e66317.
  • Hannuksela M, Förström L. Reactions to peroral propylene glycol. Contact Dermat. 1978;4:41–45.
  • Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res. 2013;15(4):e59.
  • Bekki K, Uchiyama S, Ohta K, et al. Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health. 2014;11:11192–11200.
  • Jensen RP, Luo W, Pankow JF, et al. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372:392–394.
  • Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16:1319–1326.
  • Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of aldehydes only in ‘dry puff’ conditions. Addiction. 2015;110:1352–1356.
  • Farsalinos KE, Kistler KA, Pennington A, et al. Aldehyde levels in e-cigarette aerosol: findings from a replication study and from use of a new generation device. Food Chem Toxicol. 2018 Jan;111:64–70.
  • Farsalinos KE, Voudris V. Do flavouring compounds contribute to aldehyde emissions in e-cigarettes? Food Chem Toxicol. 2018 May;115:212–217.
  • Dibaji SAR, Guha S, Arab A, et al. Accuracy of commercial electronic nicotine delivery systems (ENDS) temperature control technology. PLoS One. 2018 Nov 5;13(11):e0206937..
  • Akpinar-Elci M, Travis WD, Lynch DA, et al. Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur Respir J. 2004;24:298–302.
  • van Rooy FG, Rooyackers JM, Prokop M, et al. Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am J Respir Crit Care Med. 2007;176:498–504.
  • Farsalinos KE, Kistler KA, Gillman G, et al. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob Res. 2015;17:168–174.
  • Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring chemicals in e-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect. 2016;124(6):733–739.
  • Fujioka K, Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol. 2006;21:47–54.
  • Flavorings-related lung disease: diacetyl [Internet]. Washington, DC: Occupational Safety and Health Administration, U.S. Department of Labor; Available from: http://www.osha.gov/SLTC/flavoringlung/diacetyl.html
  • Costigan S, Meredith C. An approach to ingredient screening and toxicological risk assessment of flavours in e-liquids. Regul Toxicol Pharmacol. 2015 Jul;72(2):361–369..
  • Costigan S, Lopez-Belmonte J. An approach to allergy risk assessments for e-liquid ingredients. Regul Toxicol Pharmacol. 2017 Jul;87:1–8.
  • Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta (GA): CDC; 2010.
  • World Health Organization International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 83, tobacco smoke and involuntary smoking. Geneva: International Agency for Research on Cancer; 2004. Available from: http://monographs.iarc.fr/ENG/Monographs/vol83/mono83.pdf
  • Greenland S, Satterfield M, Lanes S. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf. 1998;18:297–308.
  • US Department of Health and Human Services. The health consequences of smoking: 50 years of progress: a report of the Surgeon General. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
  • Nides MA, Leischow SJ, Bhatter M, et al. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav. 2014;38:265–274.
  • Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacol (Berl). 2014;231:401–407.
  • Farsalinos KE, Spyrou A, Tsimopoulou K, et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133.
  • Fearon I, Eldridge A, Gale N, et al. E-cigarette nicotine delivery: data and learnings from pharmacokinetic studies. Am J Health Behav. 2017;41(1):16–32.
  • Farsalinos KE, Voudris V, Poulas K. Are metals emitted from electronic cigarettes a reason for health concern? A risk-assessment analysis of currently available literature. Int J Environ Res Public Health. 2015 May 15;12(5):5215–5232..
  • Higham A, Rattray NJ, Dewhurst JA, et al. Electronic cigarette exposure triggers neutrophil inflammatory responses. Respir Res. 2016;17:56.
  • Rubenstein DA, Hom S, Ghebrehiwet B, et al. Tobacco and e-cigarette products initiate Kupffer cell inflammatory responses. Mol Immunol. 2015 Oct;67(2Pt B):652–660..
  • Bahl V, Lin S, Xu N, et al. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol. 2012;34:529–537.
  • Behar RZ, Wang Y, Talbot P. Comparing the cytotoxicity of electronic cigarette fluids, aerosols and solvents. Tob Control. 2018 May;27(3):325–333..
  • Palpant NJ, Hofsteen P, Pabon L, et al. Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes. PLoS One. 2015 May 15;10(5):e0126259..
  • Romagna G, Allifranchini E, Bocchietto E, et al. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol. 2013;25(6):354–361.
  • Yu V, Rahimy M, Korrapati A, et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol. 2016;52:58–65.
  • Holliday R, Kist R, Bauld L. E-cigarette vapour is not inert and exposure can lead to cell damage. Evid Based Dent. 2016 Mar;17(1):2–3..
  • Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. 2015;309:L175–L187.
  • Behar RZ, Davis B, Bahl V, et al. Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro. 2014;28(2):198–208.
  • Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One. 2015;10:e0116732.
  • Azzopardi D, Patel K, Jaunky T, et al. Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol Mech Methods. 2016;26(6):477–491.
  • Leigh NJ, Lawton RI, Hershberger PA, et al. Flavourings significantly affect inhalation toxicity of aerosol generated from electronic nicotine delivery systems (ENDS). Tob Control. 2016;25(Suppl 2):ii81–ii87.
  • Anthérieu S, Garat A, Beauval N, et al. Comparison of cellular and transcriptomic effects between electronic cigarette vapor and cigarette smoke in human bronchial epithelial cells. Toxicol In Vitro. 2017 Jan 5. DOI:10.1016/j.tiv.2016.12.015.
  • Scheffler S, Dieken H, Krischenowski O, et al. Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health. 2015;12(4):3915–3925.
  • Scheffler S, Dieken H, Krischenowski O, et al. Cytotoxic evaluation of e-liquid aerosol using different lung-derived cell models. Int J Environ Res Public Health. 2015 Oct 5;12(10):12466–12474.
  • Aufderheide M, Emura M. Phenotypical changes in a differentiating immortalized bronchial epithelial cell line after exposure to mainstream cigarette smoke and e-cigarette vapor. Exp Toxicol Pathol. 2017;69(6):393–401.
  • Shen Y, Wolkowicz MJ, Kotova T, et al. Transcriptome sequencing reveals e-cigarette vapor and mainstream-smoke from tobacco cigarettes activate different gene expression profiles in human bronchial epithelial cells. Sci Rep. 2016;6:23984.
  • Neilson L, Mankus C, Thorne D, et al. Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol. Toxicol In Vitro. 2015;29(7):1952–1962.
  • Banerjee A, Haswell LE, Baxter A, et al. Differential gene expression using rna sequencing profiling in a reconstituted airway epithelium exposed to conventional cigarette smoke or electronic cigarette aerosols. Appl In Vitro Toxicol. 2017;3:84–98.
  • Haswell LE, Baxter A, Banerjee A, et al. Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics. Sci Rep. 2017;7(1):888.
  • Martin E, Clapp PW, Rebuli ME, et al. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell Mol Physiol. 2016 Jun;10(ajplung.00170.2016):DOI:10.1152/ajplung.00170.2016.
  • Vink JM, Jansen R, Brooks A, et al. Differential gene expression patterns between smokers and non-smokers: cause or consequence?. Addict Biol. 2015 Nov;22: DOI:10.1111/adb.12322.
  • Reidel B, Radicioni G, Clapp PW, et al. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med. 2018 Feb 15;197(4):492–501..
  • Takahashi K, Pavlidis S, Ng Kee Kwong F, et al. U-BIOPRED study group. Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis. Eur Respir J. 2018 Apr;12:pii: 1702173. Epub ahead of print..
  • Kesimer M, Ford AA, Ceppe A, et al. Airway mucin concentration as a marker of chronic bronchitis. N Engl J Med. 2017 Sep 7;377(10):911–922..
  • Ghosh A, Coakley RC, Mascenik T, et al. Chronic E-cigarette exposure alters the human bronchial epithelial proteome. Am J Respir Crit Care Med. 2018. DOI:10.1164/rccm.201710-2033OC
  • Gerloff J, Sundar IK, Freter R, et al. Inflammatory response and barrier dysfunction by different e-cigarette flavoring chemicals identified by gas chromatography-mass spectrometry in e-liquids and e-vapors on human lung epithelial cells and fibroblasts. Appl In Vitro Toxicol. 2017;3(1):28–40.
  • Vlahos R, Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol. 2014;5:435.
  • Scott A, Lugg ST, Aldridge K, et al. Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages. Thorax. 2018 Dec;73(12):1161–1169.
  • Sherwood CL, Boitano S. Airway epithelial cell exposure to distinct e-cigarette liquid flavorings reveals toxicity thresholds and activation of CFTR by the chocolate flavoring 2,5-dimethypyrazine. Respir Res. 2016;17(1):57.
  • Iskandar AR, Gonzalez-Suarez I, Majeed S, et al. A framework for in vitro systems toxicology assessment of e-liquids. Toxicol Mech Methods. 2016;26(6):389–413.
  • Aug A, Altraja S, Kilk K, et al. E-cigarette affects the metabolome of primary normal human bronchial epithelial cells. PLoS One. 2015;10(11):e0142053.
  • Wu Q, Jiang D, Minor M, et al. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One. 2014;9:e108342.
  • Misra M, Leverette RD, Cooper BT, et al. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health. 2014;11:11325–11347.
  • Breheny D, Oke O, Pant K, et al. The comparative tumour promotion assessment of e-cigarette and cigarettes using the in vitro Bhas 42 cell transformation assay. Environ Mol Mutagen. 2017;58:190–198.
  • Taylor M, Carr T, Oke O, et al. E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol Mech Methods. 2016;26(6):465–476.
  • CORESTA recommended method no 81, 2015. Routine analytical machine for e-cigarette aerosol generation and collection – definitions and standard conditions [Internet]. Paris: CORESTA; 2015 June. Available from: https://www.coresta.org/sites/default/files/technical_documents/main/CRM_81.pdf
  • Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med (Berl). 2016;94(6):667–679.
  • Li X. In vitro toxicity testing of cigarette smoke based on the air-liquid interface exposure: a review. Toxicol In Vitro. 2016;36:105–113.
  • Thorne D, Adamson J. A review of in vitro cigarette smoke exposure systems. Exp Toxicol Pathol. 2013;65:1183–1193.
  • Cervellati F, Muresan XM, Sticozzi C, et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro. 2014;28(5):999–1005.
  • Lerner CA, Rutagarama P, Ahmad T, et al. Electronic cigarette aerosols and copper nanoparticles induce mitochondrial stress and promote DNA fragmentation in lung fibroblasts. Biochem Biophys Res Commun. 2016;477:620–625.
  • Thorne D, Larard S, Baxter A, et al. The comparative in vitro assessment of e-cigarette and cigarette smoke aerosols using the γH2AX assay and applied dose measurements. Toxicol Lett. 2017;265:170–178.
  • Test no. 403: acute inhalation toxicity. Paris: OECD; [ cited 2009 Sept 7]. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-tg403.pdf
  • Test no. 436: acute inhalation toxicity – acute toxic class method. Paris: OECD; [ cited 2009 Sept 8]. Available from: http://www.oecd-ilibrary.org/docserver/download/9743601e.pdf
  • Test no. 412: subacute inhalation toxicity: 28-day study. Paris: OECD; [2009 Sept 7]. Available from: http://www.oecd-ilibrary.org/docserver/download/9741201e.pdf
  • Test no. 413: subchronic inhalation toxicity: 90-day study. Paris: OECD; [2009 Sept 7]. Available from: http://www.oecd-ilibrary.org/docserver/download/9741301e.pdf
  • Phillips B, Esposito M, Verbeeck J, et al. Toxicity of aerosols of nicotine and pyruvic acid (separate and combined) in Sprague-Dawley rats in a 28-day OECD 412 inhalation study and assessment of systems toxicology. Inhal Toxicol. 2015;27(9):405–431.
  • Waldum HL, Nilsen OG, Nilsen T, et al. Long-term effects of inhaled nicotine. Life Sci. 1996;58(16):1339–1346.
  • Suber RL, Deskin R, Nikiforov I, et al. Subchronic nose-only inhalation study of 951 propylene glycol in Sprague-Dawley rats. Food Chem Toxicol. 1989;27(9):573–583.
  • Laube BL, Afshar-Mohajer N, Koehler K, et al. Acute and chronic in vivo effects of exposure to nicotine and propylene glycol from an E-cigarette on mucociliary clearance in a murine model. Inhal Toxicol. 2017 Apr;29(5):197–205..
  • Glynos C, Bibli SI, Katsaounou P, et al. Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice. Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L662–L672..
  • Garcia-Arcos I, Geraghty P, Baumlin N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax. 2016;71(12):1119–1129.
  • Shapiro SD. Variable susceptibility to cigarette smoke-induced emphysema in 34 inbred strains of mice implicates Abi3bp in emphysema susceptibility. Am J Respir Cell Mol Biol. 2017 April 25. DOI:10.1165/rcmb.2016-0220OC.
  • Yao H, Edirisinghe I, Rajendrasozhan S, et al. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1174–L1186.
  • Gordon T, Bosland M. Strain-dependent differences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke. Cancer Lett. 2009;275(2):213–220.
  • Salturk Z, Ç Ç, Sünnetçi G, et al. Effects of electronic nicotine delivery system on larynx: experimental study. J Voice. 2015;29(5):560–563.
  • Werley MS, Kirkpatrick DJ, Oldham MJ, et al. Toxicological assessment of a prototype e-cigarette device and three flavor formulations: a 90-day inhalation study in rats. Inhal Toxicol. 2016;28:22–38.
  • Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary 955 anti-bacterial and anti-viral defenses in a mouse model. PLOS One. 2015;10:e0116861.
  • Lim HB, Kim SH. Inhallation of e-cigarette cartridge solution aggravates allergen-induced airway 844 inflammation and hyper-responsiveness in mice. Toxicol Res. 2014;30:13–18.
  • Husari A, Shihadeh A, Talih S, et al. Acute exposure to electronic and combustible cigarette aerosols: effects in an animal model and in human alveolar cells. Nicotine Tob Res. 2016;18(5):613–661.
  • Vardavas C, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141:1400–1406.
  • Lappas AS, Tzortzi AS, Konstantinidi EM, et al. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirology. 2018 Mar;23(3):291–297..
  • Staudt MR, Salit J, Kaner RJ, et al. Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes. Respir Res. 2018 May 14;19(1):78..
  • Flouris A, Chorti M, Poulianiti K, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91–101.
  • Ferrari M, Zanasi A, Nardi E, et al. Short-term effects of a nicotine-free e-cigarette compared to a traditional cigarette in smokers and non-smokers. BMC Pulm Med. 2015;15:120.
  • MÈ B, Henry C, Bossé Y, et al. Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals. Respir Res. 2017 Feb 10;18(1):33..
  • D’Ruiz CD, O’Connell G, Graff DW, et al. Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Regul Toxicol Pharmacol. 2017;87:36–53.
  • Cravo AS, Bush J, Sharma G, et al. A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks. Regul Toxicol Pharmacol. 2016 Nov 15;81(Suppl 1):S1–S14..
  • Cibella F, Campagna D, Caponnetto P, et al. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clin Sci (Lond). 2016;130(21):1929–1937.
  • Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133–135.
  • Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163–2173.
  • Robbins RA, Millatmal T, Lassi K, et al. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest. 1997;112:313–318.
  • Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med. 2007;176:238–242.
  • Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J. 1980;281:484–485.
  • Marini S, Buonanno G, Stabile L, et al. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol. 2014;278:9–15.
  • Schober W, Szendrei K, Matzen W, et al. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health. 2014;217:628–637.
  • Campagna D, Cibella F, Caponnetto P, et al. Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. Eur J Clin Invest. 2016;46(8):698–706.
  • Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19:1945–1953.
  • McRobbie H, Phillips A, Goniewicz ML, et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res. 2015;8:873–878.
  • Polosa R, Morjaria J, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2014;9:537–546.
  • Polosa R, Caponnetto P, Maglia M, et al. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health. 2014;14:1159.
  • Polosa R, Cibella F, Caponnetto P, et al. Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep. 2017 Nov 17;7(1):13825..
  • Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41:716–726.
  • Polosa R, Caponnetto P, Sands MF. Caring for the smoking asthmatic patient. J Allergy Clin Immunol. 2012;130(5):1221–1224.
  • Polosa R, Morjaria J, Caponnetto P, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014;11(5):4965–4977.
  • Polosa R, Morjaria JB, Caponnetto P, et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med. 2016;21(114):99–108.
  • Morjaria JB, Malerba M, Polosa R. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD. Drug Discov Today. 2010;15(9–10):396–405.
  • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–1648.
  • Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest. 2004;126:1443–1451.
  • Kanner RE, Connett JE, Williams DE, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med. 1999;106:410–416.
  • Polosa R, Morjaria JB, Prosperini U, et al. Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up. Int J Chron Obstruct Pulmon Dis. 2018Aug22;13:2533–2542.
  • Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161:381–390.
  • Tashkin DP, Rennard S, Taylor Hays J, et al. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med. 2011;105:1682–1690.
  • Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Internal Med. 2004;164:2206–2216.
  • Almirall J, Bolíbar I, Serra-Prat M, et al. Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008;31:1274–1284.
  • Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J Intern Med. 2011;269:258–269.
  • Campagna D, Amaradio MD, Sands MF, et al. Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping. Pneumonia. 2016;8:4.
  • Puck TT, Robertson OH, Lemon HM. The bactericidal action of propylene glycol vapor on microorganisms suspended in air: ii. the influence of various factors on the activity of the vapor. J Exp Med. 1943;78:387–406.
  • Robertson OH, Loosli CG, Puck TT, et al. The protection of mice against infection with air-borne influenza virus by means of propylene glycol vapor. Science. 1941;94:612–613.
  • Fuochi V, Caruso M, Emma R, et al. Electronic cigarette liquids inhibit pathogenic bacteria growth in vitro. J Antimicrob Chemother. submitted for publication to Respir Res.
  • McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195(8):1043–1049.
  • Choi K, Bernat D. E-cigarette use among Florida youth with and without asthma. Am J Prev Med. 2016;51(4):446–453.
  • Wang MP, Ho SY, Leung LT, et al. Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatr. 2016;170:89–91.
  • Cho JH, Paik SY. Association between electronic cigarette use and asthma among high school students in South Korea. PLoS One. 2016;11:e0151022.
  • Kruse GR, Kalkhoran S, Rigotti NA. Use of electronic cigarettes among U.S. Adults with medical comorbidities. Am J Prev Med. 2017 Jun;52(6):798–804..
  • Wills TA, Pagano I, Williams RJ, et al. E-cigarette use and respiratory disorder in an adult sample. Drug Alcohol Depend. 2019;194:363–370.
  • Bowler RP, Hansel NN, Jacobson S, et al. Electronic cigarette use in US adults at risk for or with COPD: analysis from two observational cohorts. J Gen Intern Med. 2017;32(12):1315–1322.
  • Nutt DJ, Phillips LD, Balfour D, et al. E-cigarettes are less harmful than smoking. Lancet. 2016;387(10024):1160–1162.
  • Caponnetto P, Saitta D, Sweanor D, et al. What to consider when regulating electronic cigarettes: pros, cons and unintended consequences. Int J Drug Policy. 2015;26(6):554–559.
  • [cited 2019 Apr 3]. Available from: https://elearning.ncsct.co.uk/e_cigarettes-launch
  • [cited 2019 Apr 3]. Available from: https://www.nhs.uk/smokefree/help-and-advice/e-cigarettes
  • [cited 2019 Apr 3]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/statistics-on-smoking/statistics-on-smoking-england-2018/content
  • Polosa R, Caponnetto P, Niaura R, et al. Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods. Intern Emerg Med. 2017 Sep;12(6):733–735.. Epub 2017 May 5.
  • CORESTA Recommended Method No 81, 2015. Routine analytical machine for e-cigarette aerosol generation and collection – Definitions and standard conditions. CRM N° 81, 2015. Available from: http://www.coresta.org/Recommended_Methods/CRM_81.pdf
  • Behrsing H, Raabe H, Manuppello J, et al. Assessment of in vitro COPD models for tobacco regulatory science: workshop proceedings, conclusions and paths forward for in vitro model use. Altern Lab Anim. 2016;44:129–166.
  • Behrsing H, Hill E, Raabe H, et al. In vitro exposure systems and dosimetry assessment tools for inhaled tobacco products: workshop proceedings, conclusions and paths forward for in vitro model use. Altern Lab Anim. 2017 Jul;45(3):117–158.
  • Caponnetto P, Campagna D, Papale G, et al. The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med. 2012 Feb; 6(1):63–74..